Cytoreductive Surgery

On this page

CRS Fundamentals - Defining the Debulk

  • CRS: Surgical removal of all visible tumor (peritoneal metastases).
  • Aim: Maximal tumor debulking for optimal outcome.
  • Significance: Enhances adjuvant therapy efficacy (e.g., HIPEC), ↑ survival.
  • Completeness of Cytoreduction (CC) Score:
    • CC-0: No visible disease (Goal).
    • CC-1: Nodules < 2.5 mm.
    • CC-2: Nodules 2.5 mm-2.5 cm.
    • CC-3: Nodules > 2.5 cm.

⭐ Achieving CC-0 (no visible residual disease) in CRS is the most crucial factor for long-term survival.

Patient Selection - Who Gets CRS?

  • Goal: Achieve complete cytoreduction (CC-0/CC-1).
  • Key Considerations:
    • Good performance status (ECOG 0-1).
    • No major comorbidities precluding major surgery.
    • Disease biology: Low-grade tumors respond better.
    • Limited extra-peritoneal disease.
    • Possibility of achieving complete cytoreduction.

⭐ The Peritoneal Cancer Index (PCI) score is a critical preoperative assessment tool to quantify disease burden and determine resectability in peritoneal surface malignancies. A PCI score < 20 is often a favorable prognostic factor.

The CRS Procedure - Surgical Showdown

  • Objective: Achieve complete macroscopic tumor removal.
  • Core Components:
    • Peritonectomy: Removal of diseased peritoneum.
    • Visceral Resections: Targeted removal of involved organs (e.g., omentum, spleen, bowel segments).
  • Completeness of Cytoreduction (CC) Score:
    • CC-0: No visible disease.
    • CC-1: Residual tumor < 2.5 mm.
    • CC-2: Residual tumor 2.5 mm - 2.5 cm.
    • CC-3: Residual tumor > 2.5 cm.

⭐ CC-0 (no macroscopic residual disease) is the single most important prognostic factor for survival in CRS patients.

HIPEC & Adjuvants - The Chemo Cocktail

  • HIPEC (Hyperthermic Intraperitoneal Chemotherapy):
    • Heated chemo (e.g., Mitomycin C, Cisplatin, Oxaliplatin) circulated in peritoneum. 📌 My Cousin Owes.
    • Temperature: 41-43°C; Duration: 60-90 minutes.
    • Goal: Eradicate microscopic residual tumor cells post-CRS.
    • Mechanism: Hyperthermia ↑ drug penetration & cytotoxicity.
  • Other Adjuvants:
    • EPIC: Early Postoperative Intraperitoneal Chemotherapy (non-heated).
    • NIPEC: Normothermic Intraperitoneal Chemotherapy.
    • Systemic Chemotherapy: Neoadjuvant or adjuvant. HIPEC Procedure Setup Diagram

⭐ Hyperthermia (typically 41-43°C) during HIPEC enhances the penetration and cytotoxic effect of chemotherapeutic agents like Mitomycin C or Cisplatin in the peritoneal cavity.

Outcomes & Complications - The Aftermath

  • Outcomes:
    • ↑ Median survival & DFS in select patients (e.g., appendiceal, ovarian, mesothelioma).
    • Prognostic Factors:
      • Completeness of Cytoreduction (CC-0/1 ideal).
      • Peritoneal Cancer Index (PCI <20 is favorable).
      • Tumor histology, grade, & careful patient selection.
  • Complications:
    • Morbidity: Significant, reported 30-50%; Mortality: <5% in experienced, high-volume centers.
    • Common: Anastomotic leak, prolonged ileus, infections (SSI, pneumonia), myelosuppression (esp. post-HIPEC), DVT/PE, fistulas.
    • Quality of Life (QoL): Initially ↓, typically improves over several months.

⭐ Major morbidity after CRS and HIPEC can be significant (up to 30-50%), with common complications including anastomotic leaks, infections, and myelosuppression; however, in experienced centers, mortality is <5%.

High‑Yield Points - ⚡ Biggest Takeaways

  • CRS (Cytoreductive Surgery) targets no gross residual disease (CC-0) in peritoneal malignancies, often combined with HIPEC.
  • Main indications: Appendiceal, colorectal, ovarian cancers, and peritoneal mesothelioma.
  • Peritoneal Cancer Index (PCI) is vital for selection; PCI >20 often excludes patients.
  • Completeness of Cytoreduction (CC score) is the strongest predictor of survival.
  • HIPEC uses heated chemotherapy (e.g., Mitomycin C, Cisplatin) to target microscopic cells post-CRS.
  • Associated with significant morbidity; requires specialized, high-volume centers for optimal outcomes.
  • Sugarbaker's principles often guide the peritonectomy techniques employed during CRS.

Practice Questions: Cytoreductive Surgery

Test your understanding with these related questions

Which classification system is currently used in North America for Wilms' tumor based on surgical and pathological findings?

1 of 5

Flashcards: Cytoreductive Surgery

1/10

Desmoid tumors have a _____ recurrence rate

TAP TO REVEAL ANSWER

Desmoid tumors have a _____ recurrence rate

high

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial